Gujarat Terce Laboratories P/B Ratio
Gujarat Terce Laboratories (GUJTERC) P/B ratio is 3.34 (High), book value per share ₹12.50 vs Healthcare average P/B of -0.33 — High - Premium to book value, growth expectations or asset-light model. Review GUJTERC earnings valuation to evaluate earnings-based valuation against sector peers.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
GUJTERC P/B Ratio — Valuation Insights & Book Value Analysis
Gujarat Terce Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 3.34 (High). View GUJTERC annual price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 3.34, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.33
Gujarat Terce Laboratories P/B Ratio Historical Trend
GUJTERC annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Gujarat Terce Laboratories share price chart.
GUJTERC Historical P/B Ratio — Book Value Per Share & Year-End Price
Gujarat Terce Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.67 | ₹12.5 | ₹33.35 | ₹10 | Moderate |
| 2025 | 4.35 | ₹10.0 | ₹43.50 | ₹7 | High |
| 2024 | 8.48 | ₹10.0 | ₹84.80 | ₹7 | High |
| 2023 | 2.85 | ₹10.0 | ₹28.49 | ₹7 | Moderate |
| 2022 | 1.42 | ₹12.86 | ₹18.25 | ₹9 | Moderate |
GUJTERC vs Healthcare Peers — P/B Ratio Comparison
Gujarat Terce Laboratories P/B 3.34 vs Healthcare average -0.33, median 0.6 — range -17.45–1.11.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.45 | ₹21 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -4.18 | ₹29 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.34 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.88 | ₹132 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.56 | ₹50 | Low |